Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 370

1.

Approach to Pandemic 2009 influenza: first report from a main referral hospital for Pandemic H1N1 influenza care in Iran.

Dashti-Khavidaki S, Khalili H, Gholamalipour F, Soudbakhsh A, Talasaz AH, Hajabdolbaghi M, Rasoolinejad M, Mokhtari Azad T, Fathi M, Talebian MT, Nasiripour S.

J Infect Dev Ctries. 2010 Oct 28;4(10):629-35.

2.

Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria.

Poeppl W, Hell M, Herkner H, Stoiser B, Fritsche G, Schurz-Bamieh N, Poeppl G, Gattringer R, Jones N, Maass M, Egle A, Burgmann H.

Infection. 2011 Aug;39(4):341-52. doi: 10.1007/s15010-011-0121-9.

PMID:
21544585
3.

Impact of early oseltamivir treatment on outcome in critically ill patients with 2009 pandemic influenza A.

Rodríguez A, Díaz E, Martín-Loeches I, Sandiumenge A, Canadell L, Díaz JJ, Figueira JC, Marques A, Alvarez-Lerma F, Vallés J, Baladín B, García-López F, Suberviola B, Zaragoza R, Trefler S, Bonastre J, Blanquer J, Rello J; H1N1 SEMICYUC Working Group..

J Antimicrob Chemother. 2011 May;66(5):1140-9. doi: 10.1093/jac/dkq511.

4.

Antiviral resistance surveillance for influenza A virus in Brazil: investigation on 2009 pandemic influenza A (H1N1) resistance to oseltamivir.

Souza TM, Mesquita M, Resende P, Machado V, Gregianini TS, Fernandes SB, Oliveira IC, Rosa Mdo C, Marinelli R, de Azeredo-Lima CH, Motta FC, Aguiar-Oliveira Mde L, Siqueira MM.

Diagn Microbiol Infect Dis. 2011 Sep;71(1):98-9. doi: 10.1016/j.diagmicrobio.2011.05.006. No abstract available.

PMID:
21784597
5.

Clinical and epidemiological characteristics of patients with influenza A (H1N1) 2009 attended to at the emergency room of a children's hospital.

Lera E, Wörner NT, Sancosmed M, Fàbregas A, Casquero A, Melendo S, Miserachs M, Tórtola T, Borrego A, Campins M, Moraga F, Figueras C, Cebrián R.

Eur J Pediatr. 2011 Mar;170(3):371-8. doi: 10.1007/s00431-011-1399-4.

PMID:
21274563
6.

2009 Influenza A H1N1 infections: delays in starting treatment with oseltamivir were associated with a more severe disease.

Launes C, García-García JJ, Jordán I, Martínez-Planas A, Selva L, Muñoz-Almagro C.

Pediatr Infect Dis J. 2011 Jul;30(7):622-5. doi: 10.1097/INF.0b013e3182093397.

PMID:
21200359
7.

Epidemiological and clinical features of 308 hospitalized patients with novel 2009 influenza A (H1N1) virus infection in China during the first pandemic wave.

Zhang G, Xia Z, Liu Y, Li X, Tan X, Tian Y, Liang L, Nie G, Zhou B.

Intervirology. 2011;54(3):164-70. doi: 10.1159/000319930.

PMID:
21051903
8.

[The 2009/2010 pandemic].

Schaberg T, Burger R.

Pneumologie. 2010 Dec;64(12):755-67; quiz 768. doi: 10.1055/s-0030-1255949. German. No abstract available.

9.

Changes in epidemiology, clinical features and severity of influenza A (H1N1) 2009 pneumonia in the first post-pandemic influenza season.

Viasus D, Cordero E, Rodríguez-Baño J, Oteo JA, Fernández-Navarro A, Ortega L, Gracia-Ahufinger I, Fariñas MC, García-Almodovar E, Payeras A, Paño-Pardo JR, Muñez-Rubio E, Carratalà J; Novel Influenza A (H1N1) Study Group of the Spanish Network for Research in Infectious Diseases (REIPI)..

Clin Microbiol Infect. 2012 Mar;18(3):E55-62. doi: 10.1111/j.1469-0691.2011.03753.x.

10.

A novel influenza A H1N1 clinical manifestations in patients at Chiang Mai University Hospital.

Chaiwarith R, Prommee N, Liwsrisakun C, Oberdorfer P, Nuntachit N, Pothirat C.

J Med Assoc Thai. 2011 Aug;94(8):908-15.

PMID:
21863671
11.

Antiviral agents: to treat or not to treat? An old dilemma revisited in light of new data from the 2009 influenza A(H1N1) pandemic.

Hernández JM, López-Rodas V, Costas E.

J Clin Virol. 2010 Oct;49(2):145-6. doi: 10.1016/j.jcv.2010.07.001. No abstract available.

PMID:
20674477
12.

Surveillance for influenza during the 2009 influenza A (H1N1) pandemic-United States, April 2009-March 2010.

Brammer L, Blanton L, Epperson S, Mustaquim D, Bishop A, Kniss K, Dhara R, Nowell M, Kamimoto L, Finelli L.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S27-35. doi: 10.1093/cid/ciq009.

13.

Timely assessment of the severity of the 2009 H1N1 influenza pandemic.

Armstrong GL, Brammer L, Finelli L.

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S83-9. doi: 10.1093/cid/ciq013.

14.

Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China.

Cao B, Li XW, Mao Y, Wang J, Lu HZ, Chen YS, Liang ZA, Liang L, Zhang SJ, Zhang B, Gu L, Lu LH, Wang DY, Wang C; National Influenza A Pandemic (H1N1) 2009 Clinical Investigation Group of China..

N Engl J Med. 2009 Dec 24;361(26):2507-17. doi: 10.1056/NEJMoa0906612.

15.

How we optimized prevention and control of pandemic 2009 influenza A (H1N1) in a resource-limited nation's pediatric oncology unit.

Melgar M, De-Leon RE, Gerónimo M, Ramírez M, Asturias EJ, Antillon-Klussmann F, Guimera D, Caniza MA.

Am J Infect Control. 2011 Aug;39(6):534-5. doi: 10.1016/j.ajic.2010.10.012. No abstract available.

PMID:
21612844
16.

Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.

Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT.

Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014.

PMID:
20869989
17.

Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States.

Graitcer SB, Gubareva L, Kamimoto L, Doshi S, Vandermeer M, Louie J, Waters C, Moore Z, Sleeman K, Okomo-Adhiambo M, Marshall SA, St George K, Pan CY, LaPlante JM, Klimov A, Fry AM.

Emerg Infect Dis. 2011 Feb;17(2):255-7. doi: 10.3201/eid1702.101724.

18.

Hospitalized patients with 2009 pandemic influenza A (H1N1) virus infection in the United States--September-October 2009.

Skarbinski J, Jain S, Bramley A, Lee EJ, Huang J, Kirschke D, Stone A, Wedlake T, Richards SM, Page S, Ragan P, Bullion L, Neises D, Williams RM, Petruccelli BP, Vandermeer M, Lofy KH, Gindler J, Finelli L; 2009 Pandemic Influenza A H1N1 Virus Fall Hospitalizations Investigation Team..

Clin Infect Dis. 2011 Jan 1;52 Suppl 1:S50-9. doi: 10.1093/cid/ciq021.

19.

Age as risk factor for death from pandemic (H1N1) 2009, Chile.

Dabanch J, Perret C, Najera M, Gonzalez C, Guerrero A, Olea A, Fasce R, Morales C; Advisory Committee of the Chilean Ministry of Health..

Emerg Infect Dis. 2011 Jul;17(7):1256-8. doi: 10.3201/eid1707.101398.

20.

Household transmission of pandemic 2009 influenza A (H1N1) virus in Osaka, Japan in May 2009.

Komiya N, Gu Y, Kamiya H, Yahata Y, Yasui Y, Taniguchi K, Okabe N.

J Infect. 2010 Oct;61(4):284-8. doi: 10.1016/j.jinf.2010.06.019.

PMID:
20670650
Items per page

Supplemental Content

Support Center